Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM.

N Engl J Med. 2005 Mar 17;352(11):1081-91.

2.

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT; Multicenter Study of Perioperative Ischemia (McSPI) Research Group.; Ischemia Research and Education Foundation (IREF) Investigators..

J Thorac Cardiovasc Surg. 2003 Jun;125(6):1481-92.

3.

Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.

Nussmeier NA, Whelton AA, Brown MT, Joshi GP, Langford RM, Singla NK, Boye ME, Verburg KM.

Anesthesiology. 2006 Mar;104(3):518-26.

PMID:
16508400
4.

Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.

Langford RM, Joshi GP, Gan TJ, Mattera MS, Chen WH, Revicki DA, Chen C, Zlateva G.

Clin Drug Investig. 2009;29(9):577-90. doi: 10.2165/11317570-000000000-00000.

PMID:
19663520
5.
6.

Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data.

Schug SA, Joshi GP, Camu F, Pan S, Cheung R.

Anesth Analg. 2009 Jan;108(1):299-307. doi: 10.1213/ane.0b013e31818ca3ac.

PMID:
19095866
7.

Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis.

Aldington S, Shirtcliffe P, Weatherall M, Beasley R.

N Z Med J. 2005 Nov 25;118(1226):U1755. Review.

PMID:
16311613
8.

Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor.

Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R, Cheung RY, Fort JG.

Anesth Analg. 2004 Feb;98(2):336-42, table of contents.

PMID:
14742366
11.

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.

Coats TL, Borenstein DG, Nangia NK, Brown MT.

Clin Ther. 2004 Aug;26(8):1249-60.

PMID:
15476906
12.

A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain.

Desjardins PJ, Shu VS, Recker DP, Verburg KM, Woolf CJ.

Anesthesiology. 2002 Sep;97(3):565-73.

PMID:
12218521
14.

Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery.

Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS, Hubbard RC.

Anesthesiology. 2002 Aug;97(2):306-14.

PMID:
12151917
15.

Effect of parecoxib on postoperative pain after lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial.

Jirarattanaphochai K, Thienthong S, Sriraj W, Jung S, Pulnitiporn A, Lertsinudom S, Foocharoen T.

Spine (Phila Pa 1976). 2008 Jan 15;33(2):132-9. doi: 10.1097/BRS.0b013e3181604529.

PMID:
18197096
16.
17.
18.

Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control.

Tang J, Li S, White PF, Chen X, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E.

Anesthesiology. 2002 Jun;96(6):1305-9.

PMID:
12170040
19.

The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively.

Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, Hubbard RC.

Anesth Analg. 2001 Sep;93(3):721-7.

PMID:
11524347
20.

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M; Adenoma Prevention with Celecoxib (APC) Study Investigators..

N Engl J Med. 2005 Mar 17;352(11):1071-80.

Items per page

Supplemental Content

Support Center